Atea Pharmaceuticals (AVIR) Shares Issued (2019 - 2026)

Atea Pharmaceuticals' Shares Issued history runs 8 years deep, the most recent figure standing at $23.4 million for Q1 2026.

• On a quarterly basis, Shares Issued rose 3.16% year-over-year to $23.4 million in Q1 2026; TTM through Mar 2026 was $23.4 million, a 3.16% increase from a year earlier, with the FY2025 full-year figure at $22.8 million, up 13.27% from the prior year.
• Shares Issued rose to $23.4 million in Q1 2026 per AVIR's latest filing, from $22.8 million in the prior quarter.
• Across five years, Shares Issued topped out at $23.4 million in Q1 2026 and bottomed at $8.1 million in Q3 2022.
• The 5-year median for Shares Issued is $16.9 million (2023), against an average of $16.2 million.
• Across the five-year window, Shares Issued surged 102.69% in 2023 and retreated 27.45% in 2024, its largest moves.
• Year by year, Shares Issued stood at $13.6 million in 2022, then advanced by 24.83% to $17.0 million in 2023, then advanced by 18.5% to $20.2 million in 2024, then advanced by 13.27% to $22.8 million in 2025, then rose by 2.55% to $23.4 million in 2026.
• Per Business Quant, the three latest AVIR Shares Issued figures stand at $23.4 million (Q1 2026), $22.8 million (Q4 2025), and $17.1 million (Q3 2025).